Newsletter Subscription

Enter Name and Email

22 March 2013 - Lectures in USA on novel "biased agonist" drugs for depression

Adrian Newman-Tancredi PhD gave two invited lectures at american academic institutions on novel drugs exhibiting "biased agonism". These drugs exhibit innovative profiles of actions (also known as "functional selectivity" and could constitute improved treatments for disorders such as schizophrenia, depression and Parkinson's disease. Adrian's lectures focused on the translational relevance of biased agonism from cellular models in vitro, through electrophysiology and neurochemistry to behavioral pharmacology and brain imaging.

The first lecture took place on 25 February 2013 at the New York State Psychiatric Institute in Manhattan. Adrian's contact there is Prof. E. David Leonardo, an expert investigator of the regulation of 5-HT1A receptors in genetic mouse models.

The second lecture took place on 28 February 2013 at the Dept. of Pharmacology of the University of Texas Health Science Center in San Antonio. Adrian was invited by Prof. Alan Frazer who is an eminent researcher in the field of mood disorders and antidepressant drugs.

If you would like to know more about Adrian's lectures and/or his ongoing engagement with academic centres of excellence, Contact.